Animal models of depression and anxiety: What do they tell us about human condition?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 6, 2011, Pages 1357-1375

  Neumann, I D ^a   Wegener, G ^b   Homberg, J R ^f   Cohen, H ^d   Slattery, D A ^a   Zohar, J ^e   Olivier, J D A ^g   Mathe A ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f RADBOUD UNIVERSITY   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Anxiety; Depression; PTSD; Translational

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; ALPRAZOLAM; ARGIPRESSIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORDIAZEPOXIDE; CITALOPRAM; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 ANTAGONIST; DIAZEPAM; NEUROPEPTIDE S; NEUROPEPTIDE Y; NITRIC OXIDE; OXYTOCIN; OXYTOCIN ANTAGONIST; PAROXETINE; PROLACTIN; SEROTONIN; SEROTONIN 2A AGONIST; SEROTONIN TRANSPORTER; SERTRALINE; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1A RECEPTOR ANTAGONIST;

ABNORMAL BEHAVIOR; ANHEDONIA; ANIMAL BEHAVIOR; ANXIETY DISORDER; CONSTRUCT VALIDITY; CORRELATIONAL STUDY; DECREASED APPETITE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE MODEL; DRUG TARGETING; FACE VALIDITY; FORCED SWIMMING TEST; GENETIC MODEL; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT GENE; LIMBIC CORTEX; LONG TERM MEMORY; MAJOR DEPRESSION; MEMORY DISORDER; MONOAMINE METABOLISM; MOUSE STRAIN; NERVE STIMULATION; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PREDICTIVE VALIDITY; RAT STRAIN; RECEPTOR BLOCKING; SHORT SURVEY; SOCIAL BEHAVIOR; SOCIAL DISABILITY; WEIGHT REDUCTION;

ANIMALS; ANXIETY; DEPRESSION; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 79960446683     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.11.028     Document Type: Short Survey

References (249)

1. Adamec R. Transmitter systems involved in neural plasticity underlying increased anxiety and defense-implications for understanding anxiety following traumatic stress. Neurosci Biobehav Rev 1997, 21:755-765.
2. Adamec R.E., Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav 1993, 54:101-109.
3. Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K.P., et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci 2006, 26(20):5554-5564.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4 ed.
5. Aydemir C., Yalcin E.S., Aksaray S., Kisa C. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1256-1260.
6. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., Janowsky D.S. Effects of chronic mild stress on serum complement activity, saccharin preference and corticosterone levels in Flinders lines of rats. Physiol Behav 1995, 57:165-169.
7. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000, 24:410-414.
8. Barr C.S., Newman T.K., Shannon C., Parker C., Dvoskin R.L., Becker M.L., et al. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry 2004, 55(7):733-738.
9. Barr C.S., Dvoskin R.L., Yuan Q., Lipsky R.H., Gupte M., Hu X., et al. CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques. Arch Gen Psychiatry 2008, 65(8):934-944. Aug.
10. Barrot M., Wallace D.L., Bolanos C.A., Graham D.L., Perrotti L.I., Neve R.L., et al. Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci USA 2005, 102:8357-8362.
11. Bartolomucci A., Carola V., Pascucci T., Puglisi-Allegra S., Cabib S., Lesch K.P., et al. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis Model Mech 2010, 3(7-8):459-470.
12. Beiderbeck D.I., Neumann I.D., Veenema A.H. Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety. Eur J Neurosci 2007, 26:3597-3605.
13. Benca R.M., Overstreet D.H., Gilliland M.A., Russell D., Bergmann B.M., Obermeyer W.H. Increased basal REM sleep but no difference in dark induction or light suppression of REM sleep in Flinders rats with cholinergic supersensitivity. Neuropsychopharmacology 1996, 15:45-51.
14. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 1998, 53(4):649-655.
15. Bjørnebekk A., Mathé A.A., Brené S. Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls. Neuropsychopharmacology 2006, 31(2):256-264. Feb.
16. Bjørnebekk A., Mathé A.A., Gruber S.H., Brené S. Social isolation increases number of newly proliferated cells in hippocampus in female flinders sensitive line rats. Hippocampus 2007, 17(12):1193-1200.
17. Bjørnebekk A., Mathé A.A., Brené S. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 2010, 20(7):820-828.
18. Blanchard R.J., Blanchard D.C., Rodgers J., Weiss S.M. The characterization and modelling of antipredator defensive behavior. Neurosci Biobehav Rev 1990, 14:463-472.
19. Blanchard R.J., Nikulina J.N., Sakai R.R., McKittrick C., McEwen B., Blanchard D.C. Behavioral and endocrine change following chronic predatory stress. Physiol Behav 1998, 63:561-569.
20. Blaveri E., Kelly F., Mallei A., Harris K., Taylor A., Reid J., et al. Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One 2010, 5(9):e12596.
21. Blume A., Bosch O.J., Miklos S., Torner L., Wales L., Waldherr M., et al. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2008, 27:1947-1956.
22. Bosch O.J., Neumann I.D. Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci USA 2009, 105:17139-17144.
23. Bosch O.J., Meddle S.L., Beiderbeck D.I., Douglas A.J., Neumann I.D. Brain oxytocin correlates with maternal aggression: link to anxiety. J Neurosci 2005, 25:6807-6815.
24. Bosch O.J., Kromer S.A., Neumann I.D. Prenatal stress: opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety. Eur J Neurosci 2006, 23(2):541-551.
25. Bouali S. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci 2003, 18(8):2203-2212.
26. Breslau N., Davis G.C., Andreski P., Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 1991, 48:216-222.
27. Breslau N., Kessler R.C., Chilcoat H.D., Schultz L.R., Davis G.C., Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 1998, 55:626-632.
28. Brigman J.L., Mathur P., Harvey-White J., Izquierdo A., Saksida L.M., Bussey T.J., et al. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex 2010, 20(8):1955-1963.
29. Bryant R.A. Recovery after the tsunami: timeline for rehabilitation. J Clin Psychiatry 2006, 67:50-55.
30. Caberlotto L., Hurd Y.L. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 2001, 25(1):91-97. Jul.
31. Caberlotto L., Jimenez P., Overstreet D.H., Hurd Y.L., Mathé A.A., Fuxe K. Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. Neurosci Lett 1999, 265(3):191-194.
32. Canli T., Lesch K.P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 2007, 10(9):1103-1109.
33. Carboni L., Becchi S., Piubelli C., Mallei A., Giambelli R., Razzoli M., et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Neuropsychopharmacol Biol Psychiatry 2010, 34(6):1037-1048.
34. Carboni L, Piubelli C, El Khoury A, Gruber S, Andersson W, Mathé AA, et al. Escitalopram treatment in the FSL rat model of depression with gene-environment interaction: proteomic analysis of hippocampus and frontal cortex. Int J Neuropsychopharmacol, in review.
35. Carola V., Frazzetto G., Pascucci T., Audero E., Puglisi-Allegra S., Cabib S., et al. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol Psychiatry 2008, 63(9):840-846.
36. Caspi A., Moffitt T. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006, 7:583-590.
37. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297(5582):851-854.
38. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
39. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167(5):509-527.
40. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260-265.
41. Chen F., Madsen T.M., Wegener G., Nyengaard J.R. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 2010, 20(12):1376-1378.
42. Cohen H., Zohar J. Animal models of post traumatic stress disorder: the use of cut off behavioral criteria. Ann N Y Acad Sci 2004, 1032:167-178.
43. Cohen H., Friedberg S., Michael M., Kotler M., Zeev K. Interaction of CCK-4 induced anxiety and post-cat exposure anxiety in rats. Depress Anxiety 1996, 4:144-145.
44. Cohen H., Kaplan Z., Kotler M. CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder. Depress Anxiety 1999, 10:8-17.
45. Cohen H., Benjamin J., Kaplan Z., Kotler M. Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model. Eur Neuropsychopharmacol 2000, 10:429-435.
46. Cohen H., Joseph Z., Matar M. The relevance of differential response to trauma in an animal model of post-traumatic stress disorder. Biol Psychiatry 2003, 53:463-473.
47. Cohen H., Zohar J., Matar M.A., Zeev K., Loewenthal U., Richter-Levin G. Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 2004, 29:1962-1970.
48. Cohen H., Zohar J., Matar M.A., Kaplan Z., Geva A.B. Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry 2005, 58:640-650.
49. Cohen H., Matar M.A., Richter-Levin G., Zohar J. The contribution of an animal model toward uncovering biological risk factors for PTSD. Ann NY Acad Sci 2006, 1071:335-350.
50. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 2006, 59:1208-1218.
51. Cohen H., Zohar J., Matar M., Loewenthal U., Kaplan Z. Post-traumatic stress behavioural responses in inbred mouse strains: can genetic predisposition explain phenotypic vulnerability?. Int J Neuropsychopharmacol 2007, 11:331-349.
52. Connor K.M., Foa E.B., Davidson J.R. Practical assessment and evaluation of mental health problems following a mass disaster. J Clin Psychiatry 2006, 67(Suppl. 2):26-33.
53. Cooper-Kuhn C.M., Kuhn H.G. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res Dev Brain Res 2002, 134(1-2):13-21.
54. Crocker A.D., Overstreet D.H. Changes in dopamine sensitivity in rats selectively bred for differences in cholinergic function. Pharmacol Biochem Behav 1991, 38:105-108.
55. Davidson J.R. Pharmacologic treatment of acute and chronic stress following trauma. J Clin Psychiatry 2006, 67(Suppl 2):34-39.
56. Diamond D.M., Campbell A.M., Park C.R., Woodson J.C., Conrad C.D., Bachstetter A.D., et al. Influence of predator stress on the consolidation versus retrieval of long-term spatial memory and hippocampal spinogenesis. Hippocampus 2006, 16(7):571-576.
57. Donner N., Bredewold R., Maloumby R., Neumann I.D. Chronic intracerebral prolactin attenuates neuronal stress circuitries in virgin rats. Eur J Neurosci 2007, 25:1804-1814.
58. El Khoury A., Gruber S.H., Mørk A., Mathé A.A. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Prog Neuropsychopharmacol 2006, 30:535-540.
59. Elfving B., Høgh Plougmann P., Kaastrup Müller H., Mathé A.A., Rosenberg R., Wegener G. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol 2010, 13(5):563-572.
60. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., et al. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 2000, 12(7):2299-2310.
61. Fairbank JA, Schlenger WE, Saigh PA, Davidson JRT. An epidemiologic profile of post-traumatic stress disorder: prevalence, comorbidity, and risk factors. In: M.J.F., D.S.C., A.Y.D. editors. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. Philadelphia: Lippincott-Raven 1995; pp. 415-427.
62. File S.E., Zangrossi H., Sanders F.L., Mabbutt P.S. Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiol Behav 1993, 54:1109-1111.
63. Foa E.B., Stein D.J., McFarlane A.C. Symptomatology and psychopathology of mental health problems after disaster. J Clin Psychiatry 2006, 67:15-25.
64. Fox M.A., Stein A.R., French H.T., Murphy D.L. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). Br J Pharmacol 2010, 159(4):879-887.
65. Gobbi G., Murphy D.L., Lesch K., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 2001, 296(3):987-995.
66. Griebel G., Blanchard D.C., Jung A., Masuda C.K., Blanchard RJ.. 5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone. Pharmacol Biochem Behav 1995, 51(2-3):235-244.
67. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006, 10(4):182-191.
68. Harlow H.F., Suomi S.J. Social recovery by isolation-reared monkeys. Proc Natl Acad Sci USA 1971, 68(7):1534-1538. Jul.
69. Harlow H.F., Zimmermann R.R. Affectional responses in the infant monkey; orphaned baby monkeys develop a strong and persistent attachment to inanimate surrogate mothers. Science 1959, 21:130(3373):421-432.
70. Hascup K.N., Hascup E.R., Gerhardt G.A., Mathé A.A., Kehr J. Neuropeptide Y modulation of the glutamatergic system in the Flinders sensitive rat: a rat model of depression. Paper presented at the ECNP Workshop in Neuropsychopharmacology, 58, March 2009 2009.
71. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38(4):213-224.
72. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjögren M., et al. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 2004, 38(2):113-121.
73. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66(6):2621-2624.
74. Heiming R.S., Jansen F., Lewejohannn L., Kaiser S., Schmitt A., Lesch K.P., et al. Living in a dangerous world: the shaping of behavioral profile by early environment and 5-HTT genotype. Front Behav Neurosci 2009, 3:26.
75. Heinrichs M., Meinlschmidt G., Neumann I., Wagner S., Kirschbaum C., Ehlert U., et al. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab 2001, 86:4798-4804.
76. Holmes A., Murphy D.L., Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002, 161(2):160-167.
77. Holmes A., Yang R.J., Murphy D.L., Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 2002, 27:914-923.
78. Homberg J.R., Olivier J.D., Smits B.M., Mul J.D., Mudde J., Verheul M., et al. Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 2007, 146(4):1662-1676.
79. Homberg J.R., de Boer S.F., Raaso H.S., Olivier J.D., Verheul M., Ronken E., et al. Adaptations in pre- and postsynaptic 5-HT(1A) receptor function and cocaine supersensitivity in serotonin transporter knockout rats. Psychopharmacology (Berl) 2008, 200(3):367-380.
80. Hou C., Jia F., Liu Y., Li L. CSF serotonin, 5-HIAA and neuropeptide Y levels in severe major depressive disorder. Brain Res 2006, 1095:154-158.
81. Huot R.L., Thrivikraman K.V., Meaney M.J., Plotsky P.M. Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment. Psychopharmacology (Berl) 2001, 158:366-373.
82. Husum H., Vasquez P.A., Mathé A.A. Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: lithium treatment normalizes tachykinins. Neuropsychopharmacology 2001, 24(2):183-191.
83. Husum H., Aznar S., Høyer-Hansen S., Larsen M.H., Mikkelsen J.D., Møller A., et al. Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IR fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: implications for the pathophysiology of depression?. J Neurosci Res 2006, 84(6):1292-1302.
84. Husum H., Wörtwein G., Andersson W., Bolwig T.G., Mathé A.A. Gene-environment interaction affects substance P and neurokinin A in the entorhinal cortex and periaqueductal grey in a genetic animal model of depression: implications for the pathophysiology of depression. Int J Neuropsychopharmacol 2008, 11(1):93-101.
85. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1085-1093.
86. Jacob C.P., Nguyen T.T., Dempfle A., Heine M., Windemuth-Kieselbach C., Baumann K., et al. A gene-environment investigation on personality traits in two independent clinical sets of adult patients with personality disorder and attention deficit/hyperactive disorder. Eur Arch Psychiatry Clin Neurosci 2010, 260(4):317-326.
87. Janowsky D.S., El-Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972, 2:632-635.
88. Janowsky D.S., Risch S.C., Parker D., Huey L.Y., Judd L.L. Increased vulnerability to cholinergic stimulation in affect disorder patients. Psychopharmacol Bull 1980, 16:29-31.
89. Janowsky D.S., Overstreet D.H., Nurnberger J.I. Is cholinergic sensitivity a genetic marker for the affective disorders?. Am J Med Genet 1994, 54:335-344.
90. Jansen F., Heiming R.S., Lewejohann L., Touma C., Palme R., Schmitt A., et al. Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood. Behav Brain Res 2010, 207(1):21-29.
91. Jiménez-Vasquez P.A., Salmi P., Ahlenius S., Mathé A.A. Neuropeptide Y in brain of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Behav Brain Res 2000, 111:115-123.
92. Jiménez-Vasquez P.A., Overstreet D.H., Mathé A.A. Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electrocon- vulsive stimuli. J Psychiatr Res 2000, 34:405-412.
93. Jiménez-Vasquez P.A., Mathé A.A., Thomas J.D., Riley E.P., Ehlers C.L. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Brain Res Dev Brain Res 2001, 131(1-2):149-152.
94. Jiménez-Vasquez P.A., Diaz-Cabiale Z., Caberlotto L., Bellido I., Overstreet D., Fuxe K., et al. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 2007, 17(4):298-308. Mar.
95. Jochum T., Boettger M.K., Wigger A., Beiderbeck D., Neumann I.D., Landgraf R., et al. Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment. Behav Brain Res 2007, 183:18-24.
96. Joeyen-Waldorf J., Edgar N., Sibille E. The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice. Brain Res 2009, 1286:84-93.
97. Jones K.L., Smith R.M., Edwards K.S., Givens B., Beversdorf D.Q. Combined effect of maternal serotonin transporter genotype and prenatal stress in modulating offspring social interaction. Int J Dev Neurosci 2010, 10.1016/j.ijdevneu.2010.05.002.
98. Kalueff A.V., Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain Res Brain Res Protoc 2004, 13(3):151-158.
99. Kalueff A.V., Tuohimaa P. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods 2005, 143(2):169-177.
100. Kalueff A.V., Gallagher P.S., Murphy D.L. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. NeuroReport 2006, 17(12):1347-1351.
101. Kalueff A.V., Aldridge J.W., LaPorte J.L., Murphy D.L., Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nat Protoc 2007, 2(10):2538-2544.
102. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 2007, 6(4):389-400.
103. Kalueff A.V., Olivier J.D., Nonkes L.J., Homberg J.R. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 2009, 2010(34 (3)):373-386.
104. Kanemaru K., Nishi K., Hasegawa S., Diksic M. Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats. Neurochem Int 2009, 54(5-6):363-371. May-Jun.
105. Karege F., Perret G., Bondolfi G., Schwald M., et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
106. Karege F., Bondolfi G., Gervasoni N., Schwald M. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005, 57:1068-1072.
107. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004, 101(49):17316-17321.
108. Keck M.E., Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 2001, 22:835-844.
109. Keck M.E., Welt T., Wigger A., Renner U., Engelmann M., Holsboer F., et al. The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Eur J Neurosci 2001, 13:373-380.
110. Keck M.E., Wigger A., Welt T., Muller M.B., Gesing A., Reul J.M., et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 2002, 26:94-105.
111. Keck M.E., Welt T., Muller M.B., Uhr M., Ohl F., Wigger A., et al. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 2003, 28:235-243.
112. Kendler, Myers The genetic and environmental relationship between major depression and the five-factor model of personality. Psychol Med 2010, 40(5):801-806. May.
113. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005, 62(5):529-535.
114. Kessler M.S., Bosch O.J., Bunck M., Landgraf R., Neumann I.D. Maternal care differs in mice bred for high versus low trait anxiety: impact of brain vasopressin and cross-fostering. Soc Neurosci 2010, 21:1-13.
115. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., et al. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 2005, 49(6):798-810.
116. Kim-Cohen J., Caspi A., Taylor A., Williams B., Newcombe R., Craig I.W., et al. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006, 11(10):903-913.
117. Kornack D.R., Rakic P. Cell proliferation without neurogenesis in adult primate neocortex. Science 2001, 294(5549):2127-2130.
118. Kovacević T., Skelin I., Diksic M. Chronic fluoxetine treatment has a larger effect on the density of a serotonin transporter in the Flinders Sensitive Line (FSL) rat model of depression than in normal rats. Synapse 2010, 64:231-240.
119. Kozlovsky N., Matar M., Kaplan Z., Zohar J., Cohen H. The role of the galaninergic system in modulating stress-related responses in an animal model of PTSD. Biol Psychiatry 2009, 65:383-391.
120. Kuan C.Y., Schloemer A.J., Lu A., Burns K.A., Weng W.L., Williams M.T., et al. Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci 2004, 24(47):10763-10772.
121. Lancel M., Müller-Preuss P., Wigger A., Landgraf R., Holsboer F. The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. J Psychiatr Res 2002, 36(4):197-208.
122. Landgraf R., Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet 2002, 32:301-314.
123. Landgraf R., Wigger A., Holsboer F., Neumann I.D. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J Neuroendocrinol 1999, 11:405-407.
124. Landgraf R., Kessler M.S., Bunck M., Murgatroyd C., Spengler D., Zimbelmann M., et al. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev 2007, 31:89-102.
125. Leonard S.K., Dwyer J.M., Sukoff Rizzo S.J., Platt B., Logue S.F., Neal S.J., et al. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology 2008, 197:601-611.
126. Lewejohann L., Kloke V., Heiming R.S., Jansen F., Kaiser S., Schmitt A., et al. Social status and day-to-day behaviour of male serotonin transporter knockout mice. Behav Brain Res 2010, 211(2):220-228.
127. Li Q., Wichems C., Heils A., Van De Kar L.D., Lesch K.P., Murphy D.L. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Ther 1999, 291(3):999-1007.
128. Liebsch G., Linthorst A.C., Neumann I.D., Reul J.M., Holsboer F., Landgraf R. Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior. Neuropsychopharmacology 1998, 19:381-396.
129. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 2003, 54(10):960-971.
130. Lucassen P.J., Bosch O.J., Jousma E., Krömer S.A., Andrew R., Seckl J.R., et al. Prenatal stress reduces postnatal neurogenesis in rats selectively bred for high, but not low, anxiety: possible key role of placental 11beta-hydroxysteroid dehydrogenase type 2. Eur J Neurosci 2009, 29:97-103.
131. Mannoury la Cour, Boni C., Hanoun N., Lesch K.P., Hamon M., Lanfumey L. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. J Neurosci 2001, 21(6):2178-2185.
132. Mantella R.C., Vollmer R.R., Li X., Amico J.A. Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 2003, 144:2291-2296.
133. Matar M.A., Cohen H., Kaplan Z., Zohar J. The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:2610-2618.
134. Matar M., Zohar J., Kaplan Z., Cohen H. Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD. Eur Neuropsychopharmacol 2009, 19:283-295.
135. Mathé A.A., Rudorfer M.V., Stenfors C., Manji H.K., Potter W.C., Theodorsson E. Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin and neurokinin A concentrations in cerebrospinal fluid of depressed patients. Depression 1996, 3:250-257.
136. Mathé A.A., Husum H., El Khoury A., Jiménez-Vasquez P., Gruber S.H., Wörtwein G., et al. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?. Physiol Behav 2007, 92(1-2):226-231.
137. Mathé A, Liu T, Zohar J, Cohen H. Brain neuropeptide Y (NPY) may be a marker of posttraumatic stress disorder (PTSD) in an animal model. Submitted for publication.
138. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 2004, 140(1-2):169-181.
139. Matthews K., Baldo B.A., Markou A., Lown O., Overstreet D.H., Koob G.F. Failure to observe differences in rewarding electrical brain stimulation between Flinders sensitive and Flinders resistant rats. Physiol Behav 1996, 59:1155-1162.
140. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
141. Molteni R., Calabrese F., Maj P.F., Olivier J.D., Racagni G., Ellenbroek B.A., et al. Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats. Eur Neuropsychopharmacol 2009, 19(12):898-904.
142. Molteni R., Cattaneo A., Calabrese F., Macchi F., Olivier J.D., Racagni G., et al. Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis 2010, 37(3):747-755.
143. Morgan C.A., Wang S., Southwick S.M., Rasmusson A., Hazlett G., Hauger R.L. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry 2000, 47:902-909.
144. Morgan C.A., Rasmusson A.M., Wang S., Hoyt G., Hauger R.L., Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry 2002, 52(2):136-142.
145. Muigg P., Hoelzl U., Palfrader K., Neumann I., Wigger A., Landgraf R., et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 2007, 61:782-796.
146. Muigg P., Hetzenauer A., Hauer G., Hauschild M., Gaburro S., Frank E., et al. Impaired extinction of learned fear in rats selectively bred for high anxiety-evidence of altered neuronal processing in prefrontal-amygdala pathways. Eur J Neurosci 2008, 28:2299-2309.
147. Munafo M.R., Durrant C., Lewis G., Flint J. Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 2009, 65(3):211-219.
148. Munafo M.R., Freimer N.B., Ng W., Ophoff R., Veijola J., Miettunen J., et al. 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(2):271-281.
149. Murgatroyd C., Wigger A., Frank E., Singewald N., Bunck M., Holsboer F., et al. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J Neurosci 2004, 24:7762-7770.
150. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmühl Y., Fischer D., et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009, 12:1559-1566.
151. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 2008, 9(2):85-96.
152. Murphy D.L., Wichems C., Andrews A.M., Li Q., Hamer D., Greenberg B.D. Consequences of engineered and spontaneous genetic alterations of the 5-HT transporter in mice, men and women. Behav Pharmacol 1999, 10(suppl. 1):S65.
153. Musazzi L., Mallei A., Tardito D., Gruber S.H., El Khoury A., Racagni G., et al. Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression. Psychiatr Res 2010, 44(8):511-520. Jun.
154. Nemeroff C.B. Early-life adversity, CRF dysregulation, and vulnerability to mood and anxiety disorders. Psychopharmacol Bull 2004, 38(Suppl 1):14-20.
155. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol 2008, 20(6):858-865.
156. Neumann I.D., Wigger A., Liebsch G., Holsboer F., Landgraf R. Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behaviour. Psychoneuroendocrinology 1998, 23:449-463.
157. Neumann I.D., Johnstone H., Hatzinger M., Landgraf R., Russell J.A., Douglas A. Neuroendocrine adaptations of the hypothalamo-pituitary-adrenal (HPA) axis throughout pregnancy. J Physiol 1998, 508:289-300.
158. Neumann I., Torner L., Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 2000, 95:567-575.
159. Neumann I.D., Wigger A., Krömer S., Frank E., Landgraf R., Bosch O.J. Differential effects of periodic maternal separation on adult stress coping in a rat model of extremes in trait anxiety. Neuroscience 2005, 132:867-877.
160. Neumann I.D., Kromer S.A., Bosch O.J. Effects of psycho-social stress during pregnancy on neuroendocrine and behavioural parameters in lactation depend on the genetically determined stress vulnerability. Psychoneuroendocrinology 2005, 30:791-806.
161. Neumann I.D., Veenema A.H., Beiderbeck D.I. Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci 2010, 4:12.
162. Newman T.K., Syagailo Y.V., Barr C.S., Wendland J.R., Champoux M., Graessle M., et al. Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys. Biol Psychiatry 2005, 57(2):167-172. Jan 15.
163. Nikisch G., Mathé A.A. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur Psychiatry 2008, 23(5):356-359. Aug.
164. Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathé A.A. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int J Neuropsychopharmacol 2005, 8(3):403-410.
165. Nishi K., Kanemaru K., Hasegawa S., Watanabe A., Diksic M. Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. Neurochem Int 2009, 54:205-214.
166. Nishi K., Kanemaru K., Diksic M. A genetic rat model of depression, Flinders sensitive line, has a lower density of 5-HT(1A) receptors, but a higher density of 5-HT(1B) receptors, compared to control rats. Neurochem Int 2009, 54:299-307.
167. Nutt D., Davidson J. Post-traumatic stress disorder diagnosis, management and treatment 2000, Taylor & Francis, London.
168. Ohl F., Toschi N., Wigger A., Henniger M.S., Landgraf R. Dimensions of emotionality in a rat model of innate anxiety. Behav Neurosci 2001, 115:429-436.
169. Olivier J.D., Cools A.R., Olivier B., Homberg J.R., Cuppen E., Ellenbroek B.A. Stress-induced hyperthermia and basal body temperature are mediated by different 5-HT(1A) receptor populations: a study in SERT knockout rats. Eur J Pharmacol 2008, 590:190-197.
170. Olivier J.D., Van Der Hart M.G., Van Swelm R.P., Dederen P.J., Homberg J.R., Cremers T., et al. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 2008, 152(3):573-584.
171. Olivier J.D.A., Jans L.A., Blokland A., Broers N.J., Homberg J.R., Ellenbroek B.A., et al. Serotonin transporter deficiency in rats contributes to impaired object memory. Genes Brain Behav 2009, 8(8):829-834.
172. Olivier J.D., Cools A.R., Deen P.M., Olivier B., Ellenbroek B.A. Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters. Eur J Pharmacol 2010, 629:7-11.
173. Olsson A., Regnéll G., Träskman-Bendz L., Ekman R., Westrin A. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment. Eur Neuropsychopharmacol 2004, 14:479-485.
174. Orsetti M., Canonico P.L., Dellarole A., Colella L., Di B.F., Ghi P. Quetiapine prevents anhedonia induced by acute or chronic stress. Neuropsychopharmacology 2007, 32(8):1783-1790.
175. Overstreet D.H. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 1993, 17:51-68.
176. Overstreet D.H. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 2002, 32:335-348.
177. Overstreet D.H., Gabriel G. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Eur J Pharmacol 2004, 497(1):49-53.
178. Overstreet D.H., Russel R.W., Helps S.C., Messenger M. Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berl) 1979, 65(1):15-20. Sep.
179. Overstreet D.H., Russell R.W. Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 1982, 78(2):150-155.
180. Overstreet D.H., Janowsky D.S., Pucilowski O., Rezvani A.H. Swim test immobility cosegregates with serotonergic but not cholinergic sensitivity in cross breeds of Flinders Line rats. Psychiatr Genet 1994, 4:101-107.
181. Overstreet D.H., Friedman E., Mathé A.A., Yadid G. The Flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005, 29:739-759.
182. Owens M., Overstreet D.H., Knight D.L., Rezvani A.H., Ritchie J.C., Bissette G., et al. Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity. Neuropsychopharmacology 1991, 4:87-94.
183. Papp M., Willner P., Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 1991, 104(2):255-259.
184. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 2008, 19:566-574.
185. Petersén A., Wörtwein G., Gruber S.H., Mathé A.A. Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 2008, 436(3):305-308.
186. Petersén A., Wörtwein G., Gruber S.H., El-Khoury A., Mathé A.A. Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 2009, 451:148-151.
187. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
188. Popa D., Lena C., Alexandre C., Adrien J. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 2008, 28(14):3546-3554.
189. Pucilowski O., Overstreet D.H., Rezvani A.H., Janowsky D.S. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 1993, 54:1215-1220.
190. Qu Y., Villacreses N., Murphy D.L., Rapoport S.I. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) 2005, 180(1):12-20.
191. Rakic P. Adult neurogenesis in mammals: an identity crisis. J Neurosci 2002, 22(3):614-618.
192. Rasmusson A.M., Southwick S.M., Hauger R.L., Charney D.S. Plasma neuropeptide y (npy) increases in humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology 1998, 19(1):95-98.
193. Rasmusson A.M., Hauger R.L., Morgan C.A., Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide y (npy) levels in combat-related ptsd. Biol Psychiatry 2000, 47(6):526-539.
194. Reber S.O., Birkeneder L., Veenema A.H., Obermeier F., Falk W., Straub R.H., et al. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 2007, 148:670-682.
195. Reber S.O., Obermeier F., Straub R.H., Veenema A.H., Neumann I.D. Aggravation of DSS-induced colitis after chronic subordinate colony (CSC) housing is partially mediated by adrenal mechanisms. Stress 2008, 11:225-234.
196. Reif A., Rosler M., Freitag C.M., Schneider M., Eujen A., Kissling C., et al. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 2007, 32(11):2375-2383.
197. Resnick H., Yehuda R., Pitman R., Foy D. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry 1995, 152:1675-1677.
198. Ring R.H., Malberg J.E., Potestio L., Ping J., Boikess S., Luo B., et al. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 2006, 185:218-225.
199. Rioux A., Fabre V., Lesch K.P., Moessner R., Murphy D.L., Lanfumey L., et al. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci Lett 1999, 262(2):113-116.
200. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301(23):2462-2471. Jun 17. Erratum in: JAMA. 2009, 302(5):492.
201. Ruhé H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007, 12(4):331-359.
202. Russell R.W., Overstreet D.H., Messenger M., Helps S.C. Selective breeding for sensitivity to DFP. Generalization of effects beyond criterion variables. Pharmacol Biochem Behav 1982, l7:885-891.
203. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry 2009, 66(7):705-707.
204. Salchner P., Sartori S.B., Sinner C., Wigger A., Frank E., Landgraf R., et al. Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 2006, 50:1048-1058.
205. Salome N., Salchner P., Viltart O., Sequeira H., Wigger A., Landgraf R., et al. Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats. Biol Psychiatry 2004, 55:715-723.
206. Sartori S.B., Hauschild M., Muigg P., Neumann I., Singewald N. Modulation of impaired fear extinction by neuropeptides in a psychopathological animal model of high trait anxiety. 9th World Congress of Biological Psychiatry abstract, Paris, France 2009.
207. Schiller G.D., Daws L.C., Overstreet D.H., Orbach J. Absence of anxiety in an animal model of depression with cholinergic supersensitivity. Brain Res Bull 1991, 26:443-447.
208. Schiller G.D., Pucilowski O., Wienicke C., Overstreet D.H. Immobility-reducing effect of antidepressants in a genetic animal model of depression. Brain Res Bull 1992, 28:821-823.
209. Schwandt M.L., Lindell S.G., Chen S., Higley J.D., Suomi S.J., Heilig M., et al. Alcohol response and consumption in adolescent rhesus macaques: life history and genetic influences. Alcohol 2010, 44(1):67-80.
210. Shalev A.Y. Acute stress reactions in adults. Biol Psychiatry 2002, 51:532-543.
211. Shanahan N.A., Holick Pierz K.A., Masten V.L., Waeber C., Ansorge M., Gingrich J.A., et al. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 2009, 65(5):401-408.
212. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., et al. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004, 29(10):1790-1799.
213. Shimizu E., Hashimoto K., Okamura N., Koike K. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
214. Shiromani P.J., Overstreet D.H., Levy D., Goodrich C.A., Campbell S.S., Gillin J.C. Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology 1988, 1:127-133.
215. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 2007, 31:18-40.
216. Slattery D.A., Neumann I.D. No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. J Physiol 2008, 586:377-385.
217. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
218. Slattery D.A., Neumann I.D. The role of neuropeptides in the aetiology and potential treatment of major depressive disorders. Pharmaceuticals 2010, 3:702-724.
219. Slattery D.A., Finger B.C., Maloumby R., Wegener G., Mathé A.A., Neumann I.D. Neuropeptide S alters affective behaviour in high (HAB) but not low anxiety-related (LAB) rats. 38th SFN annual meeting abstract 2008, Washington, USA 2008.
220. Slattery D.A., Neumann I., Cryan C.F. Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat. J Psychopharmacol 2010, doi: 10.1177/0269881110368873.
221. Snoeren E., Chan J., Bovens A., Cuppen E., Waldinger M., Olivier B., et al. Serotonin transporter null mutation and sexual behavior in female rats: 5-HT1A receptor desensitization. J Sex Med 2010, 7(7):2424-2434.
222. Spinelli S., Schwandt M.L., Lindell S.G., Newman T.K., Heilig M., Suomi S.J., et al. Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigm. Dev Psychopathol 2007, 19(4):977-987.
223. Stein M.B., Schork N.J., Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 2008, 33(2):312-319.
224. Suomi S.J., Collins M.L., Harlow H.F., Ruppenthal G.C. Effects of maternal and peer separations on young monkeys. J Child Psychol Psychiatry 1976, 17(2):101-112. Apr.
225. Thase M.E., Rush A.J. Treatment-resistant depression. Psychopharmacology: the fourth generation of progress 1995, 1081-1097. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
226. Torner L., Toschi N., Pohlinger A., Landgraf R., Neumann I.D. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J Neurosci 2001, 21:3207-3214.
227. Torner L., Maloumby R., Nava G., Aranda J., Clapp C., Neumann I.D. In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. Eur J Neurosci 2004, 19:1601-1608.
228. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010, 15(1):18-22.
229. Veenema A.H., Torner L., Blume A., Beiderbeck D.I., Neumann I.D. Low inborn anxiety correlates with high intermale aggression: link to ACTH response and neuronal activation of the hypothalamic paraventricular nucleus. Horm Behav 2007, 51:11-19.
230. Vitale G., Filaferro M., Ruggieri V., Pennella S., Frigeri C., Rizzi A., et al. Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 2008, 29:2286-2291.
231. Waldherr M., Neumann I.D. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc Natl Acad Sci USA 2007, 104:16681-16684.
232. Wegener G., Harvey B.H., Bonefeld B., Müller H.K., Volke V., Overstreet D.H., et al. Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression. Int J Neuropsychopharmacol 2009, Page 1 of 13.
233. Wellman C.L., Izquierdo A., Garrett J.E., Martin K.P., Carroll J., Millstein R., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 2007, 27(3):684-691.
234. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 1992, 59(1):73-80.
235. Wigger A., Neumann I.D. Periodic maternal deprivation induces gender-dependent alterations in behavioral and neuroendocrine responses to emotional stress in adult rats. Physiol Behav 1999, 66:293-302.
236. Wigger A., Sanchez M.M., Mathys K.C., Ebner K., Frank E., Liu D., et al. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 2004, 29:1-14.
237. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52(2):90-110.
238. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
239. Wörtwein G., Husum H., Andersson W., Bolwig T.G., Mathé A.A. Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: a study of gene-environment interactions. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(4):684-693.
240. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43:487-497.
241. Yadid G., Overstreet D.H., Zangen A. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Res 2001, 896:43-47.
242. Yehuda R., Brand S., Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 2006, 59:660-663.
243. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006, 163(9):1588-1593.
244. Zambello E., Fuchs E., Abumaria N., Rygula R., Domenici E., Caberlotto L. Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(1):122-130.
245. Zambello E., Jiménez-Vasquez P.A., El Khoury A., Mathé A.A., Caberlotto L. Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(3):651-661.
246. Zangen A., Overstreet D.H., Yadid G. Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res 1999, 824(2):243-250.
247. Zangen A., Nakash R., Overstreet D.H., Yadid G. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 2001, 155:434-439.
248. Zhao S., Edwards J., Carroll J., Wiedholz L., Millstein R.A., Jaing C., et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 2006, 140(1):321-334.
249. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., et al. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452(7190):997-1000.